WallStSmart
MDGL

Madrigal Pharmaceuticals Inc

NASDAQ: MDGL · HEALTHCARE · BIOTECHNOLOGY

$518.58
+0.37% today

Updated 2026-04-29

Market cap
$11.96B
P/E ratio
P/S ratio
12.48x
EPS (TTM)
$-12.87
Dividend yield
52W range
$265 – $615
Volume
0.4M

Madrigal Pharmaceuticals Inc (MDGL) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-52.98M$27.22M$-37.94M$-26.81M$-38.20M$-47.30M$-54.13M$-77.41M$-78.92M$-71.44M$-17.61M$-22.32M$-25.51M$-41.62M$-157.56M$-183.92M$-224.86M$-324.23M$-455.57M$-189.55M
Capital expenditures$1.58M$2.35M$2.18M$454000.00$136000.00$690000.00$505000.00$769000.00$144000.00$58000.00$3080.00$125000.00$22000.00$172000.00$334000.00$209000.00$217000.00$1.48M$1.46M$467000.00
Depreciation
Stock-based comp$4.79M$5.42M$7.57M$4.58M$4.05M$3.35M$3.32M$6.03M$7.43M$4.30M$8.68M$3.25M$13.49M$22.76M$20.73M$26.87M$31.63M$49.73M$79.88M$98.13M
Free cash flow$-54.56M$24.87M$-40.12M$-27.26M$-38.34M$-47.99M$-54.64M$-78.18M$-79.07M$-71.50M$-17.61M$-22.44M$-25.53M$-41.80M$-157.90M$-184.13M$-225.07M$-325.71M$-457.03M$-190.02M
Investing cash flow
Financing cash flow
Dividends paid$1.86M$0.00$115500.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-1.24M$51.44M$-33.02M$-2.47M$-11.06M$18.84M$129.48M$-91.25M$-10.68M$7.31M$-17.73M$295.28M